SCHEMBL2938840

SCHEMBL2938840

O=S(=O)(F)CCc1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.60
PRSS1 P07477 1/20 0.60
PRSS2 P07478 1/20 0.60
ELANE P08246 1/20 0.60
PRTN3 P24158 1/20 0.60
PRSS3 P35030 1/20 0.60
CA2 P00918 4/20 0.53
MGLL Q99685 8/20 0.51
CA1 P00915 2/20 0.50
CA12 O43570 1/20 0.50
CA7 P43166 1/20 0.50
CA13 Q8N1Q1 1/20 0.50
IDO1 P14902 1/20 0.50
LMNA P02545 1/20 0.46
CA9 Q16790 1/20 0.45
MMP1 P03956 1/20 0.44
MMP7 P09237 1/20 0.44
MMP8 P22894 1/20 0.44
MMP12 P39900 1/20 0.44
MMP13 P45452 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31540566 0.87 MMP12 (0.59) FAAHPRSS1PRSS2ELANEPRTN3
SCHEMBL31540567 0.87 MMP12 (0.59) FAAHPRSS1PRSS2ELANEPRTN3
SCHEMBL1171862 0.86 MGLL (0.61) FAAHPRSS1PRSS2ELANEPRTN3
SCHEMBL28669871 0.85 MGLL (0.69) FAAHPRSS1PRSS2ELANEPRTN3
SCHEMBL1172022 0.83 MGLL (0.71) FAAHPRSS1PRSS2ELANEPRTN3
SCHEMBL1171704 0.83 MGLL (0.71) FAAHPRSS1PRSS2ELANEPRTN3
SCHEMBL29001419 0.81 MEN1 (0.49) CA2MGLLCA1CA12LMNA
SCHEMBL302785 0.80 CA2 (0.69) FAAHPRSS1PRSS2ELANEPRTN3
SCHEMBL29001390 0.79 MGLL (0.48) CA2MGLLCA1CA12IDO1
SCHEMBL29001431 0.78 MGLL (0.58) MGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 134 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12390424-B2 Sulfur (VI) fluoride compounds and methods for the preparation thereof THE SCRIPPS RESEARCH INSTITUTE (US) 2025-08-19 US disclosed
EP-4295841-A2 SULFUR (VI) FLUORIDE COMPOUNDS AND THEIR USE IN CLICK-REACTION The Scripps Research Institute (US) 2023-12-27 EP disclosed
EP-3892610-B1 SULFUR (VI) FLUORIDE COMPOUNDS AND THEIR USE IN CLICK-REACTION SCRIPPS RESEARCH INST (US) 2023-08-16 EP disclosed
US-20220313624-A1 SULFUR (VI) FLUORIDE COMPOUNDS AND METHODS FOR THE PREPARATION THEREOF THE SCRIPPS RESEARCH INSTITUTE (US) 2022-10-06 US disclosed
CN-114560793-A Free radical type fluorosulfonation reagent and preparation method and application thereof 中山大学 2022-05-31 CN disclosed
CN-108828126-B Method for qualitatively identifying strawberry stigma protein based on two-dimensional liquid chromatography tandem mass spectrometry 杭州市农业科学研究院 2020-06-02 CN disclosed
CN-107072992-A Polymorphs of celecoxib 卡尔约药物治疗公司 2017-08-18 CN disclosed
US-8853448-B2 Aromatic sulfonylimides, preparation thereof and use thereof as electrolyte INSTITUT NATIONAL POLYTECHNIQUE DE GRENOBLE (FR) 2014-10-07 US disclosed
EP-1371663-B1 ANHYDROTHROMBIN DERIVATIVES AND PROCESS FOR PRODUCING THE SAME, PLATELET AGGLUTINATION-INDUCING COMPOSITIONS, METHOD OF INDUCING PLATELET AGGLUTINATION, CLINICAL TEST REAGENTS, CLINICAL TEST METHOD, THROMBOSIS INHIBITORS, ADSORBENT AND PROCESS FUJIMORI KOGYO CO LTD (JP) 2010-09-22 EP disclosed
US-7790366-B1 NANBV diagnostics and vaccines NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US) 2010-09-07 US disclosed
WO-1989010416-A1 PROTECTIVE PEPTIDES DERIVED FROM HUMAN IMMUNODEFICIENCY VIRUS-1 gp160 TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 1989-11-02 WO disclosed
WO-1989007608-A1 BLOCKING, ISOLATING AND PURIFYING CALCIUM CHANNELS NEW YORK UNIVERSITY (US) 1989-08-24 WO disclosed
WO-1989003394-A1 ANTIGEN RECOGNIZED BY NATURAL KILLER AND NON-SPECIFIC CYTOTOXIC CELLS UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 1989-04-20 WO disclosed
EP-0304292-A2 Antibody to propeptide of procollagen type III, and assay method using it ORION-YHTYMÀ„ OY (FI) 1989-02-22 EP disclosed
WO-1988008980-A1 TYPE III COLLAGEN DEGRADATION ASSAY FARMOS-YHTYMÄ OY (FI) 1988-11-17 WO disclosed
EP-0151579-A4 METHOD AND PRODUCTS FOR DETECTION OF HUMAN T CELL LEUKEMIA VIRUS. HARVARD COLLEGE (US) 1988-09-28 EP disclosed
EP-0203107-A1 SPECIFIC CARBOHYDRATE-BINDING PROTEINS (LECTINS) OF MAMMALIAN TUMOR CELLS. MAX PLANCK GESELLSCHAFT (DE) 1986-12-03 EP disclosed
WO-1986002651-A2 SPECIFIC CARBOHYDRATE-BINDING PROTEINS (LECTINS) OF MAMMALIAN TUMOR CELLS MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSC (DE) 1986-05-09 WO disclosed
EP-0151579-A1 METHOD AND PRODUCTS FOR DETECTION OF HUMAN T CELL LEUKEMIA VIRUS. HARVARD COLLEGE (US) 1985-08-21 EP disclosed
WO-1984004327-A1 METHOD AND PRODUCTS FOR DETECTION OF HUMAN T CELL LEUKEMIA VIRUS HARVARD COLLEGE (US) 1984-11-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12390424-B2 Sulfur (VI) fluoride compounds and methods for the preparation thereof GRB2, SCTR, OGFR FAAH 2579/4885PRSS1 2129/4885PRSS2 1293/4885
US-20220313624-A1 SULFUR (VI) FLUORIDE COMPOUNDS AND METHODS FOR THE PREPARATION THEREOF QSOX1, YBX1, SFXN1 FAAH 2423/4885PRSS1 2417/4885PRSS2 2530/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.